Midline Lumbar Fusion Versus Posterior Lumbar Interbody Fusion

Degenerative Lumbar Spondylolisthesis Clinical Trial

Official title: Minimal Access Midline Lumbar Fusion Versus Traditional Open Posterior Lumbar Interbody Fusion for Degenerative Lumbar Spondylolisthesis

Status Recruiting

Clinical Trial Summary

Degenerative lumbar spondylolisthesis is the forward displacement (slip) of one vertebra on an adjacent vertebra resulting in narrowing of the spinal canal or compression of the exiting nerve roots. It is commonly associated with low back and leg pain, and is a frequent reason for spine surgery particularly in individuals over age 65 years. Recently novel minimally invasive surgical techniques have heightened public and government interest by touting benefits of reduced approached-related morbidity which in turn leads to quicker recovery, shorter hospital stay, improved short-term clinical outcomes, and reduced health care cost. However, there is no randomized controlled trial evidence to describe the actual advantages and disadvantages associated with minimally invasive spinal fusion. This pilot study is a randomized control trial comparing minimally invasive MID-line Lumbar Fusion (MIDLF) to traditional "open" posterior lumbar interbody fusion (PLIF) with respect to length of stay, approach related morbidity, patient centered outcome measures, and cost-effectiveness in the treatment of degenerative lumbar spondylolisthesis.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Degenerative Lumbar Spondylolisthesis
• Spondylolisthesis

• NCT number: NCT02290314
• Study type: Interventional
• Source: The London Spine Centre
• Contact: Jennifer Urquhart
• Phone: 5196858500
• Email: jennifer.urquhart@lhsc.on.ca
• Status: Recruiting
• Phase: N/A
• Start date: December 2014
• Completion date: December 2019